Innovative Biologics was established in December, 2003 and its research is supported by the NIH SBIR Phase II grant “Small molecule blockers of B. anthracis toxin.” Our company is located on the Prince Williams campus of George Mason University.
Our focus is to search for new anti-microbial drugs targeting bacterial toxins.
Copyright 2005. Created and Maintained by WSI.
This site is optimized for Netscape 5 and Internet Explorer 5 or higher.
Please download an updated version now.
